You are here

BeneFIX Drug Use Results Survey [All-Case Surveillance]

Last updated on February 17, 2019

FOR MORE INFORMATION
Study Location
Tokyo Medical University Hospital
Shinjuku-ku, Tokyo, Japan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hemophilia B
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- All patients with hemophilia B scheduled to receive treatment with BeneFIX will be
eligible for the surveillance.

- No patient will be excluded because of prior inhibitor history; however, complete
patient history and demographics will be collected.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients not administered BeneFIX.

NCT01154231
Pfizer
Completed
BeneFIX Drug Use Results Survey [All-Case Surveillance]

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now